1997
DOI: 10.1002/(sici)1097-0339(199702)16:2<132::aid-dc7>3.0.co;2-j
|View full text |Cite
|
Sign up to set email alerts
|

Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0
1

Year Published

1999
1999
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(25 citation statements)
references
References 14 publications
1
23
0
1
Order By: Relevance
“…CD44 -, CD133 -CD44 ? , and CD133 -CD44 -cell fractions in serum free medium differentiation genes such as CK20 [20] and MUC2 showed low expression, suggesting undifferentiated state of CD133 ? CD44 ?…”
Section: Resultsmentioning
confidence: 99%
“…CD44 -, CD133 -CD44 ? , and CD133 -CD44 -cell fractions in serum free medium differentiation genes such as CK20 [20] and MUC2 showed low expression, suggesting undifferentiated state of CD133 ? CD44 ?…”
Section: Resultsmentioning
confidence: 99%
“…CK7 labels a wide range of normal and cancerous epithelial cells, but not those of the gastrointestinal tract, whereas CK20 is selectively distributed in gastrointestinal epithelia, urothelia, Merkel cells, and tumors arising from these cells. Whereas a CK7Ϫ/CK20ϩ immunophenotype is characteristic of colorectal carcinomas, up to 25% of cases show a different immunophenotype, such as CK7ϩ/CK20ϩ, and other types of adenocarcinomas can show a similar immunophenotypic profile (17)(18)(19)(20)(21)(22). To evaluate whether nuclear ␤-catenin can be used as an adjunct marker for distinguishing colorectal carcinomas from adenocarcinomas at other organ sites, CKϩ tumors were selected for examination.…”
Section: Introductionmentioning
confidence: 99%
“…Cytokeratins, belonging to the intermediate fila- Previous examination has demonstrated CK 7 and CK 8 positivity in the vast majority of lung adenocarcinomas studied [7,22]. Using commercially available monoclonal antibody for CK8, we demonstrated a sensitivity of 72% for lung adenocarcinomas.…”
Section: Discussionmentioning
confidence: 66%